These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 12422251)
1. Adverse drug reactions to protease inhibitors. Manchanda T; Schiedel D; Fischer D; Dekaban GA; Rieder MJ Can J Clin Pharmacol; 2002; 9(3):137-46. PubMed ID: 12422251 [TBL] [Abstract][Full Text] [Related]
2. [Effects of high grade antiretroviral therapy on body fat distribution and metabolism]. Schwenk A Zentralbl Gynakol; 1999; 121(11):552-3. PubMed ID: 10612226 [No Abstract] [Full Text] [Related]
3. Are changes in body shape due to drug side effects? TreatmentUpdate; 1999 Jun; 11(4):3-4. PubMed ID: 11366790 [TBL] [Abstract][Full Text] [Related]
4. Fat, sugar and drugs on the French Riviera. Lands L GMHC Treat Issues; 1999 Mar; 13(3):9-11. PubMed ID: 11366205 [TBL] [Abstract][Full Text] [Related]
5. Changes in body shape and metabolic abnormalities. Res Initiat Treat Action; 1999 Jan; 5(1):18. PubMed ID: 11366225 [TBL] [Abstract][Full Text] [Related]
7. Metabolic complications of protease inhibitors: what have we learned so far? Erbelding EJ Hopkins HIV Rep; 1999 Mar; 11(2):5, 15. PubMed ID: 11366249 [TBL] [Abstract][Full Text] [Related]
8. [Lipodystrophy and metabolic disorders in anti-HIV therapy]. Behrens GM; Stoll M; Schmidt RE MMW Fortschr Med; 2000 Mar; 142 Suppl 1():68-71. PubMed ID: 10863318 [TBL] [Abstract][Full Text] [Related]
10. HAL in 2001: a fat oddity. Grinberg L; Torres G GMHC Treat Issues; 1999 Mar; 13(3):2-5, 8. PubMed ID: 11366203 [TBL] [Abstract][Full Text] [Related]
11. Metabolic complications of HIV infection: translating research findings into clinical practice. Currier J AIDS Clin Care; 2002 Jan; 14(1):1-2, 8. PubMed ID: 11802627 [TBL] [Abstract][Full Text] [Related]
12. [Metabolic complications associated with use of protease inhibitors]. Mosnier-Pudar H Ann Med Interne (Paris); 2000 Jun; 151(4):278-82. PubMed ID: 10922955 [TBL] [Abstract][Full Text] [Related]
14. Metabolic disorders among HIV-infected patients treated with protease inhibitors: a review. Graham NM J Acquir Immune Defic Syndr; 2000 Oct; 25 Suppl 1():S4-11. PubMed ID: 11126425 [TBL] [Abstract][Full Text] [Related]
15. Effects of metformin or gemfibrozil on the lipodystrophy of HIV-infected patients receiving protease inhibitors. Martínez E; Domingo P; Ribera E; Milinkovic A; Arroyo JA; Conget I; Pérez-Cuevas JB; Casamitjana R; de Lazzari E; Bianchi L; Montserrat E; Roca M; Burgos R; Arnaiz JA; Gatell JM Antivir Ther; 2003 Oct; 8(5):403-10. PubMed ID: 14640387 [TBL] [Abstract][Full Text] [Related]
16. Current concepts of metabolic abnormalities in HIV patients: focus on lipodystrophy. Kolter DP AIDS Read; 2003 Dec; 13(12 Suppl):S5-13. PubMed ID: 14959694 [TBL] [Abstract][Full Text] [Related]
17. Tuberous and tendinous xanthomata secondary to ritonavir-associated hyperlipidemia. Brown CA; Lesher JL; Peterson CM J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S86-9. PubMed ID: 15858517 [TBL] [Abstract][Full Text] [Related]
18. Sex differences in adverse reactions to antiretroviral drugs. Ofotokun I; Pomeroy C Top HIV Med; 2003; 11(2):55-9. PubMed ID: 12717043 [TBL] [Abstract][Full Text] [Related]